Cancer Research UK is planning to invest nearly £9m over the next five years into research at the Cancer Research UK & UCL Cancer Trials Centre. The announcement is part of a £45 million investment into Cancer Research UK’s network of clinical trials units across the UK, one of the charity’s largest investments in clinical research to date.
Publication date: 15 February 2018
A UK wide research network for osteosarcoma, a rare type of bone cancer primarily affecting teenagers and young adults, is to be set up by UCL, led by Professor Adrienne Flanagan, thanks to a generous gift of £1m from The Tom Prince Cancer Trust.
Publication date: 14 February 2018
Smoking just one cigarette a day carries a much higher risk of developing coronary heart disease and stroke than expected – about half the risk of smoking 20 per day – concludes a new study published in the BMJ today. The findings could have consequences for many smokers and health professionals who believe that smoking only a few cigarettes per day bears little or no harm.
Publication date: 25 January 2018
Researchers have discovered a new way of potentially treating mature T cell cancers using immunotherapy. The study, published in Nature Medicine, demonstrates how chimeric antigen receptor (CAR) T cells can be used to selectively target cancerous T cells.
Publication date: 22 December 2017
A new drug to delay the spread of ovarian cancer, which was developed from UCL research, has been licensed for use in the UK. Professor Jonathan Ledermann, who led the research, said the drug was a “critical milestone” in managing the disease if the cancer recurs after chemotherapy.
Publication date: 20 December 2017